Novartis (NYSE-ADR:NVS) is based in Switzerland. It has a focus on cancer drugs and also owns Sandoz. It has a market cap of $223.8 bn, a price to earnings ratio of 31.12 and a dividend yield of 3.19per cent. Guest Nesan Nair, Sasfin Securities and resident expert Paul Theron from Vestact decide whether Novartis is hot or not.